Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…
Overview
Gocovri is a prescription drug approved by the U.S.Food and Drug Administration (FDA) to treat dyskinesia (movement disorder) in people with Parkinson’s disease who are also receiving levodopa-based therapy.… read more
Overview
Inbrija is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat “off” episodes in people with Parkinson’s disease (PD) who are taking oral levodopa/carbidopa.
Inbrija is an… read more
Overview
Osmolex ER is an extended-release formulation of amantadine that is approved by the U.S. Food and Drug Administration (FDA) to treat symptoms of Parkinson’s disease, such as stiffness, tremors, and shaking. It is…
Overview
Vyalev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. This treatment is intended for individuals who experience…
Overview
Seroquel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Seroquel is also known by its drug name, quetiapine. Seroquel is sometimes prescribed… read more
Overview
Eldepryl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1989 to treat motor symptoms in people with Parkinson’s disease. Eldepryl may be prescribed as a monotherapy to people… read more
Overview
Kynmobi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for acute, intermittent treatment of “off” episodes in people with Parkinson’s disease. Kynmobi is also referred to by… read more
Overview
Ongentys is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with Parkinson’s experiencing “off” episodes. Ongentys is also referred to by its drug name, opicapone.… read more
Overview
Nourianz is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with Parkinson’s experiencing “off” episodes. Nourianz is also referred to by its drug name, istradefylline.… read more